These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 18275071

  • 1. Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
    Din S, Dahele A, Fennel J, Aitken S, Shand AG, Arnott ID, Satsangi J.
    Inflamm Bowel Dis; 2008 Jun; 14(6):756-62. PubMed ID: 18275071
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Huang Z, Chao K, Li M, Zhi M, Tang J, Hu P, Gao X.
    Inflamm Bowel Dis; 2017 Mar; 23(3):440-447. PubMed ID: 28129286
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
    Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P.
    J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA, McDonald JW, Feagan BG.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD003459. PubMed ID: 15674908
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ, Dubinsky MC, Ford AC, Ullman TA, Talley NJ, Moayyedi P.
    Am J Gastroenterol; 2011 Apr 25; 106(4):630-42. PubMed ID: 21407186
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA, McDonald JW, Feagan BG.
    Cochrane Database Syst Rev; 2003 Apr 25; (1):CD003459. PubMed ID: 12535475
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y.
    J Pediatr Gastroenterol Nutr; 2009 May 25; 48(5):526-30. PubMed ID: 19412004
    [Abstract] [Full Text] [Related]

  • 8. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.
    Kopylov U, Katsanos KH, van der Woude CJ, Karmiris K, Hernandez V, Odes S, Papamichael K, Koutroubakis IE, Bojic D, Kaimakliotis I, Fiorino G, Papageorgiou N, Pineda JR, Strongili K, Sanroman L, Mantzaris GJ, Jojic N, Paspatis G, Christodoulou DK, Ben-Horin S, Tsianos EV.
    Eur J Gastroenterol Hepatol; 2016 Jul 25; 28(7):802-6. PubMed ID: 26894634
    [Abstract] [Full Text] [Related]

  • 9. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
    Domènech E, Mañosa M, Navarro M, Masnou H, Garcia-Planella E, Zabana Y, Cabré E, Gassull MA.
    J Clin Gastroenterol; 2008 Apr 25; 42(4):395-9. PubMed ID: 18277899
    [Abstract] [Full Text] [Related]

  • 10. Parenteral Methotrexate Is Efficient in the Treatment of Azathioprine Refractory Crohn's Disease.
    Gökbulut V, Özin Y, Kalkan İH, Arı D, Yüksel M, Kılıç ZMY, Kayaçetin E.
    Turk J Gastroenterol; 2022 Feb 25; 33(2):111-118. PubMed ID: 35115294
    [Abstract] [Full Text] [Related]

  • 11. [The efficacy and safety of methotrexate in refractory Crohn's disease].
    Xu P, He Y, Chen Y, Chao K, Chen B, Mao R, Tang R, Zhu Z, Zeng Z, Chen M.
    Zhonghua Nei Ke Za Zhi; 2014 Mar 25; 53(3):188-92. PubMed ID: 24767205
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
    Hojsak I, Mišak Z, Jadrešin O, Močić Pavić A, Kolaček S.
    Scand J Gastroenterol; 2015 Mar 25; 50(10):1208-13. PubMed ID: 25877164
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate for maintenance of remission in chronic active Crohn's disease: long-term single-center experience and meta-analysis of observational studies.
    Hausmann J, Zabel K, Herrmann E, Schröder O.
    Inflamm Bowel Dis; 2010 Jul 25; 16(7):1195-202. PubMed ID: 19924799
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.
    Uhlen S, Belbouab R, Narebski K, Goulet O, Schmitz J, Cézard JP, Turck D, Ruemmele FM.
    Inflamm Bowel Dis; 2006 Nov 25; 12(11):1053-7. PubMed ID: 17075346
    [Abstract] [Full Text] [Related]

  • 15. Experience with the use of low-dose methotrexate for inflammatory bowel disease.
    Soon SY, Ansari A, Yaneza M, Raoof S, Hirst J, Sanderson JD.
    Eur J Gastroenterol Hepatol; 2004 Sep 25; 16(9):921-6. PubMed ID: 15316419
    [Abstract] [Full Text] [Related]

  • 16. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
    Harris RE, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Bigot L, Ruemmele FM, Russell RK, PIBD SETQuality consortium and PIBDnet.
    BMJ Open; 2020 Jul 01; 10(7):e034892. PubMed ID: 32611737
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Willot S, Noble A, Deslandres C.
    Inflamm Bowel Dis; 2011 Dec 01; 17(12):2521-6. PubMed ID: 21337668
    [Abstract] [Full Text] [Related]

  • 18. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
    Klimczak K, Łykowska-Szuber L, Krela-Kaźmierczak I, Eder P, Szymczak A, Stawczyk-Eder K, Linke K.
    Wiad Lek; 2016 Dec 01; 69(2 Pt 2):262-6. PubMed ID: 27487545
    [Abstract] [Full Text] [Related]

  • 19. [A Case of Crohn's Disease Showing Favorable Response to Induction and Maintenance Therapy with Methotrexate after Failure of Anti-tumor Necrosis Factor Therapy].
    Choi JR, Yun GW, Park YM, Kim JH, Youn YH, Park HJ, Park JJ.
    Korean J Gastroenterol; 2015 Oct 01; 66(4):231-6. PubMed ID: 26493510
    [Abstract] [Full Text] [Related]

  • 20. Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.
    Sunseri W, Hyams JS, Lerer T, Mack DR, Griffiths AM, Otley AR, Rosh JR, Carvalho R, Grossman AB, Cabrera J, Pfefferkorn MD, Rick J, Leleiko NS, Hitch MC, Oliva-Hemker M, Saeed SA, Kappelman M, Markowitz J, Keljo DJ, Pediatric Inflammatory Bowel Disease Collaborative Research Group.
    Inflamm Bowel Dis; 2014 Aug 01; 20(8):1341-5. PubMed ID: 24983976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.